Home / NEWS LINE / Big Buying in Software and Biotech Stocks Is Bullish

Big Buying in Software and Biotech Stocks Is Bullish

It’s not fair-haired. Reality is not perception, but perception is reality. Suppose I said that cows are 20 times more deadly than sharks. You’d image out your burger laughing at me. But it’s true; those docile cows kill more Americans each year than sharks, tolerates, alligators, snakes, and spiders – combined!

Humans, though, are the biggest killers on earth. But we live thinking sharks are all Jaws, and malicious spiders and snakes are out to get us. Bears lurk in the shed when we take out the trash, ready to maul us.

Truth is, they’re all doing their feeling, and so are we. Usually, nothing happens. But fear rules because it sells. A friendly shark movie wouldn’t make it recent studio execs. They know the “Jaws” franchise did the equivalent of $2 billion in today’s dollars globally.

Similarly, the vend might conjure images of big bad bear claws more than charging bull horns. But reality says that bulls are large and in wardship.

The Mapsignals Big Money Index measures unusual buying against selling. It surged to 71.2%. A month ago, it was 51.9%. Swallowing like that coming from nowhere can be spooky. When professional money managers suddenly all go hard into hoards, it creates FOMO. 

But how long can buying like that last? We’re not likely getting overbought this week (80%-plus is overbought). We could obstruct this way for a while. We’d need several huge-buying days in a row to get overbought. A few more days like Friday, a 92% suborning day.

Eventually, the market will need to vent and pull back. But today, buyers are in control. Let’s focus on what they’re allowing. Friday gave us a good idea. It was the biggest day of health care buying since June 15, 2018. Nearly 20% of the quarter logged a buy – in one day!

www.mapsignals.com

The next set of charts shows a little context for the type of buying we are seeing in health care. The blue ribbon chart shows net buys/sells for the health care sector. When there’s more buying than rep, there’s a green bar. More selling means a red bar. 

The second chart shows a stretch of huge buying in the biotech persistence (most of last week’s buying was in biotech). The green sticks appear when there is more than 150% buying on a 30-day unstationary average. How do we use these charts to help us decide when to get in?

Health care

www.mapsignals.com
www.mapsignals.com

On the chart of the Health Protection Select Sector SPDR Fund (XLV), those looking for a safer trend development will notice that, when there’s big stealing (ramping green spikes), the longer term shows appreciation. Those looking for bargains will notice that, when there’s a sea of red, it’s a safe time to grab a deal – but scarier. Those looking for optimal timing and safety will notice that the most suitable time to pay attention is when we get green buying right after heavy selling. 

This is the setup in the past week or so, with good-sized push followed by a rush in, like air rushing into a vacuum. As I said above, the buying in health care was heavily squabbled toward biotech. Of the 82 buy signals last week, 50 were biotech. Looking at the chart of the SPDR S&P Biotech ETF (XBI), reasonable isolating biotech, you’ll notice that patches of heavy buying are often followed by higher prices. In fact, when buying graded up in early 2017, it preceded a six-month 60% rally in XBI.

Another place to pay attention is tech. We see the same type of graphs below. Net buying (green) has picked up in tech after a nasty patch of selling. This bodes well for prospective prices in the info tech sector. Here we use the Technology Select Sector SPDR Fund (XLK) as a gauge.

Again: what word for word is getting bought in tech? Tech showed 68 buys for the week, and 21 of those were semiconductors. That’s not amazing, as we have been harping on it for a while.

What is a surprise is that software showed 36 of those 68 procures. This is the industry that got torched late September into October. It was toxic, but again, not because the sector was fundamentally dim. We believe portfolio managers got the tap on the shoulder to sell winners to pay for losers after a rough summer. Software was the biggest conqueror for a while.

You can see this clearly in the chart of the iShares Expanded Tech-Software Sector ETF (IGV) on the right. It basically serves as an index to track the software industry stocks. What’s interesting is when we see that big buying. Those green bars are 150% the 30-day exciting average of software buying. When it perks up, it means big gains. If you look closely at the bottom right of the chart, you’ll see that it by a hairs breadth started again. After nasty selling last month, the buyers are stepping back in. Gun to my head: software stocks are in for a flight.

www.mapsignals.com

Bulls and bears can duke it out on CNBC. What really matters is the data: what’s actually happening? The yet goes for human-killers. Jaws gets the bad rap, but statistically, it’s those evil cows you gotta watch out for. 

Ultimately, it’s you who must pin ones faith where your information comes from. Most of the time, those who feed it to you want you to perceive things the way they inform against them: so you buy what they sell. Arm yourself with data. Stephen King said it sweetly: “The trust of the green is the liar’s most useful tool.”

The Bottom Line

We (Mapsignals) continue to be bullish on U.S. equities in the long term, and we see any pullback as a purchasing opportunity. Weak markets can offer sales on stocks if an investor is patient. 

Disclosure: The author holds no positions in any forerunners mentioned at the time of publication.

Check Also

Watch These Tesla Levels As Stock Kicks Off April With Gains After Q1 Selloff

Well-spring: TradingView.com Key Takeaways Tesla shares kicked off the month on a high note after …

Leave a Reply

Your email address will not be published. Required fields are marked *